Fate Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Fate Therapeutics generated cash of -$132,263,000, which is more than the previous year. Cash used in financing activities reached the amount of $85,000 last year. Net change in cash is therefore -$19,513,000.
Cash Flow
| 2014 | -22.41M | -882K | 18.36M |
|---|---|---|---|
| 2015 | -18.39M | -1.49M | 35.60M |
| 2016 | -29.82M | -4.11M | 57.73M |
| 2017 | -36.90M | -10.19M | 47.44M |
| 2018 | -38.65M | -463K | 140.78M |
| 2019 | -83.17M | -157.45M | 149.92M |
| 2020 | -39.22M | -161.07M | 282.83M |
| 2021 | -162.87M | -324.02M | 453.12M |
| 2022 | -248.20M | 166.75M | 9.20M |
| 2023 | -132.26M | 112.66M | 85K |
FATE Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 76.56M | 148.81M | 182.57M | 100.04M | 190.74M | 89.07M | 88.73M | 64.80M | 49.10M | 54.03M |
Operating activities | ||||||||||
Net income | -160.92M | -281.72M | -212.15M | -173.38M | -98.14M | -66.59M | -42.95M | -33.46M | -29.99M | -25.88M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 18.28M | 13.75M | 5.85M | 3.08M | 2.19M | 1.20M | 971K | 881K | 687K | 496K |
Stock-based compensation expense | 43.45M | 78.73M | 54.36M | 30.75M | 17.41M | 0 | 3.60M | 3.18M | 2.4M | 2.43M |
| Deferred income tax benefit | 43.45M | 78.73M | 54.36M | 30.75M | 17.41M | 0 | 3.60M | 3.18M | 2.4M | 2.43M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 36.65M | -29.80M | -3.16M | -5.51M | 500K | -500K | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | -5.90M | 1.55M | -4.27M | -4.25M | 0 | 0 | 0 | 0 |
Accounts payable | -28.94M | 14.25M | 5.90M | -1.55M | 4.27M | 4.25M | 2.51M | 1.56M | 477K | 0 |
Cash generated by operating activities | -132.26M | -248.20M | -162.87M | -39.22M | -83.17M | -38.65M | -36.90M | -29.82M | -18.39M | -22.41M |
Investing activities | ||||||||||
Purchases Of Investments | -358.81M | -404.79M | -968.15M | -277.34M | -248.85M | -55.66M | -39.97M | -19.67M | 0 | 0 |
Investments In Property Plant And Equipment | -6.15M | -35.56M | -50.70M | -4.93M | -7.39M | -2.30M | -1.72M | -457K | -1.49M | -882K |
Acquisitions Net | 0 | -202.31M | 273.31M | 156.14M | 150.05M | 0 | 0 | 18K | 0 | 0 |
Cash generated by investing activities | 112.66M | 166.75M | -324.02M | -161.07M | -157.45M | -463K | -10.19M | -4.11M | -1.49M | -882K |
Financing activities | ||||||||||
Common Stock Issued | 85K | 9.20M | 453.12M | 282.34M | 162.40M | 0 | 43.20M | 28.84M | 36.72M | 142K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 186K | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | -15M | 0 | 4.14M | -7.68M | -1.54M | -1.75M |
Cash used in financing activities | 85K | 9.20M | 453.12M | 282.83M | 149.92M | 140.78M | 47.44M | 57.73M | 35.60M | 18.36M |
Net Change In Cash | -19.51M | -72.25M | -33.76M | 82.53M | -90.7M | 101.66M | 343K | 23.8M | 15.70M | -4.93M |
Cash at end of period | 57.04M | 76.56M | 148.81M | 182.57M | 100.04M | 190.74M | 89.07M | 88.60M | 64.80M | 49.10M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |